Dry Weight Management in Hemodialysis

Clinical Importance

Achieving the true dry weight is essential for controlling blood pressure and should be the first‑line therapy for hypertensive patients receiving hemodialysis【1】【2】【3】.
Expansion of the extracellular fluid volume is a major contributor to hypertension in hemodialysis patients【1】.
Proper dry‑weight control can improve left‑ventricular hypertrophy and reduce arterial stiffness【2】【3】.

Determination of dry weight remains largely a clinical assessment based on signs of hypo‑ or hypervolemia【1】【2】【3】.
Bioimpedance analysis is an emerging technology that can quantitatively assess body‑fluid compartments and aid dry‑weight estimation【2】.

Dry‑weight reduction should be performed gradually over 4–12 weeks (or longer) with continuous monitoring of patient tolerance during and between dialysis sessions【2】【3】.
In the DRIP randomized trial, a stepwise reduction of dry weight (≈0.1 kg per 10 kg of body weight) produced an additional ≈7 mm Hg drop in ambulatory systolic blood pressure after 8 weeks【2】【3】 (Level A evidence).

Adverse events such as symptomatic hypotension and seizures have been reported during aggressive dry‑weight probing【2】【3】.
More gradual reductions are better tolerated and reduce the incidence of these adverse events【2】【3】.
Setting a target weight that is too low can precipitate hypotension and accelerate loss of residual renal function【4】.
Setting a target weight that is too high leads to persistent hypervolemia【4】.

Interdialytic weight gain is driven by fluid and sodium intake between treatments【2】【3】.
High dialysate sodium concentrations increase thirst, interdialytic weight gain, and blood‑pressure elevation【1】【2】.
The “target weight” (objective weight) differs from the estimated dry weight and may be adjusted from session to session; in acute illness or severe symptoms, a slightly higher target weight may be justified, but chronic volume overload risks must be carefully weighed【4】.

In hemodialysis patients, a weight gain of 1 kg corresponds to approximately 1 L of excess fluid, providing the basis for determining the ultrafiltration volume needed to return to dry weight. 5

Setting the target dry weight too low precipitates intradialytic hypotension and accelerates loss of residual renal function, whereas setting it too high maintains persistent hypervolemia, increasing cardiovascular risk. 5

An ultrafiltration rate exceeding 10 mL·h⁻¹·kg⁻¹ is associated with higher mortality and end‑organ ischemia in hemodialysis patients, indicating that UF rates should be kept below this level. 5

Applying a uniform ultrafiltration rate limit to all patients without considering individual hemodynamics, comorbidities, and symptoms can lead to inappropriate fluid removal and adverse outcomes; individualized assessment is recommended. 5